Series date: 
01/01/2025 - 12:00pm MST to 12/31/2025 - 1:00pm MST

Activity Description:

This Cardiovascular and Thoracic Service Line Grand Round series aims to bring together health professionals from various specialties and fields to improve knowledge about cardiovascular and thoracic topics. Evidence-based lectures and discussion surrounding various cardiac, vascular and thoracic diagnostics, care techniques, and treatment options will help providers improve clinical performance resulting in more comprehensive care for patients. The primary outcome for this series is to address the critical need for state-of-the-art, contemporary education for medical teams.

Target Audience: 

Attendees may include physicians, nurses, physician assistants, nurse practitioners, medical students, and other medical professionals seeking to expand their knowledge in this field.

Learning Objectives:

  • Present and discuss the rapid evolution of the field of thoracic oncology.
  • Examine the importance of molecular cancer testing and therapeutic decision making.
  • Assess the importance of early multidisciplinary discussion in patient care and long term outcomes.

Moderator:

Denise Mathias

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. 

Series location: 
HCA HealthONE Swedish
501 E. Hampden Ave
Hybrid
Englewood, CO 80113
United States